Tangible Shareholders Equity: The value shareholders equity less intangible assets.
ABVC BioPharma, Inc. (ABVC) had Tangible Shareholders Equity of $0.72M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.51M |
|
$-4.90M |
|
$0.00M |
|
$0.51M |
|
$5.21M |
|
$-4.71M |
|
$-0.66M |
|
$-5.37M |
|
$-5.03M |
|
$-5.26M |
|
$-5.26M |
|
$-5.26M |
|
$-4.91M |
|
$-4.71M |
|
$-4.50M |
|
11.67M |
|
11.67M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$2.18M |
|
$0.51M |
|
$5.36M |
|
$7.54M |
|
$6.56M |
|
-- |
|
$0.26M |
|
$6.82M |
|
$0.72M |
|
|
Tangible Shareholders Equity |
$0.72M |
$0.72M |
|
13.87M |
|
| Cash Flow Statement Financials | |
$-1.81M |
|
-- |
|
$1.98M |
|
$0.72M |
|
$0.86M |
|
$0.15M |
|
$2.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.33 |
|
-- |
|
-- |
|
-- |
|
2.47 |
|
99.85% |
|
-923.34% |
|
-923.34% |
|
-883.91% |
|
-1053.71% |
|
-962.12% |
|
$-1.81M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
0.44 |
|
827.32 |
|
-726.43% |
|
-726.43% |
|
-69.75% |
|
-726.43% |
|
$0.05 |
|
$-0.15 |
|
$-0.15 |
|